Robert A. Lenz

Insider Reports History

Entity
Individual
Location
C/O Neumora Therapeutics, Inc., 490 Arsenal Way, Suite 200, Watertown, MA
Signature
/s/ Joshua Pinto, as Attorney-in-Fact for Robert A. Lenz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert A. Lenz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Neumora Therapeutics, Inc. Head of R&D Common Stock 315K $4.75M $15.09 Oct 10, 2024 Direct
Neumora Therapeutics, Inc. Head of R&D Stock Option (Right to Buy) 100K Feb 14, 2024 Direct

Insider Reports Filed by Robert A. Lenz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NMRA Neumora Therapeutics, Inc. Oct 9, 2024 2 -$208K 4 Oct 11, 2024 Head of R&D
NMRA Neumora Therapeutics, Inc. Sep 17, 2024 2 -$493K 4 Sep 19, 2024 Head of R&D
NMRA Neumora Therapeutics, Inc. Sep 12, 2024 1 -$377K 4 Sep 16, 2024 Head of R&D
NMRA Neumora Therapeutics, Inc. Feb 14, 2024 2 $0 4 Feb 16, 2024 Head of R&D
NMRA Neumora Therapeutics, Inc. Sep 14, 2023 2 $0 4 Sep 18, 2023 Head of R&D
NMRA Neumora Therapeutics, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 Head of R&D